Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Current Cardiology Reports
|
March 21, 2013
Is ischemia the most powerful indicator of myocardial viability?
Jamshid Shirani
Current Cardiology Reports
|
April 29, 2010
Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?
Jamshid Shirani, Vasken Dilsizian
Current Cardiology Reports
|
February 25, 2009
Molecular imaging targets of cardiac remodeling
Jamshid Shirani, Vasken Dilsizian
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 26, 2010
Nuclear cardiac imaging in hypertrophic cardiomyopathy
Jamshid Shirani, Vasken Dilsizian
Nature Clinical Practice. Cardiovascular Medicine
|
July 25, 2008
Imaging left ventricular remodeling: targeting the neurohumoral axis
Jamshid Shirani, Vasken Dilsizian
Current Cardiology Reports
|
March 4, 2014
Novel molecular angiotensin converting enzyme and angiotensin receptor imaging techniques
Jamshid Shirani, Vasken Dilsizian
Texas Heart Institute Journal
|
May 14, 2009
Pulmonary artery embolization of ventriculoatrial shunt fragment
Andrew So, Jamshid Shirani
Journal of Cardiology
|
January 16, 2025
In-hospital mortality and risk factors in critically ill patients with hypertrophic cardiomyopathy
Zhiyuan Ma, Jamshid Shirani
Current Opinion in Biotechnology
|
January 6, 2007
Molecular imaging in heart failure
Jamshid Shirani, Vasken Dilsizian
Current Cardiology Reports
|
May 22, 2019
The Cardiorenal Axis: Myocardial Perfusion, Metabolism, and Innervation
Jamshid Shirani, Srinidhi Meera, Vasken Dilsizian
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Current Cardiology Reports
|
March 21, 2013
Is ischemia the most powerful indicator of myocardial viability?
Jamshid Shirani
Current Cardiology Reports
|
April 29, 2010
Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?
Jamshid Shirani, Vasken Dilsizian
Current Cardiology Reports
|
February 25, 2009
Molecular imaging targets of cardiac remodeling
Jamshid Shirani, Vasken Dilsizian
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 26, 2010
Nuclear cardiac imaging in hypertrophic cardiomyopathy
Jamshid Shirani, Vasken Dilsizian
Nature Clinical Practice. Cardiovascular Medicine
|
July 25, 2008
Imaging left ventricular remodeling: targeting the neurohumoral axis
Jamshid Shirani, Vasken Dilsizian
Current Cardiology Reports
|
March 4, 2014
Novel molecular angiotensin converting enzyme and angiotensin receptor imaging techniques
Jamshid Shirani, Vasken Dilsizian
Texas Heart Institute Journal
|
May 14, 2009
Pulmonary artery embolization of ventriculoatrial shunt fragment
Andrew So, Jamshid Shirani
Journal of Cardiology
|
January 16, 2025
In-hospital mortality and risk factors in critically ill patients with hypertrophic cardiomyopathy
Zhiyuan Ma, Jamshid Shirani
Current Opinion in Biotechnology
|
January 6, 2007
Molecular imaging in heart failure
Jamshid Shirani, Vasken Dilsizian
Current Cardiology Reports
|
May 22, 2019
The Cardiorenal Axis: Myocardial Perfusion, Metabolism, and Innervation
Jamshid Shirani, Srinidhi Meera, Vasken Dilsizian
Page
of 10